Global Lipid Nanoparticles CDMO Market Analysis & Research Report 2027 - Evonik, Merck, CordenPharma, Phosphorex, eTheRNA

Lipid nanoparticles are nanoparticles composed of lipids. These are spherical vesicles made of ionizable lipids, and lipid nanoparticles that a key role in effectively protecting and transporting mRNA to cells. Over the past few years, it has emerged as an emerging vehicle for delivering a variety of therapeutics.

Lipid Nanoparticles (LNPs) Acceptance in the Fight Against COVID-19 Triggers the Lipid Nanoparticles CDMO Market Growth

Lipids are molecules which make up the building blocks of living cells and are very important for mRNA-based drugs. The mRNA is surrounded by a lipid nanoparticle (LNP) composed of specific lipids. The LNP guards the mRNA from degradation and delivers it safely into the cell, where it is released. Presently, LNPs are considered the most advanced drug delivery system and due to their versatility have gained worldwide acceptance in the fight against COVID-19.

“The effectiveness of mRNA vaccines against COVID-19 pandemic boosted the demand for lipid nanoparticle (LNP)-mediated drug delivery for RNA vaccines and therapeutics. As projects entered into the commercialization stage from the clinical trial stage, developers were challenged to maintain consistency in LNP formulation as the essential quantities increased.”-Senior Scientist, Lipid Nanoparticle CDMO, USA

Strong Pipeline of Lipid Nanoparticles (LNP)-Related Drugs Propels the Lipid Nanoparticles CDMO Market Growth

LNPs possess the capability to deliver unstable genetic materials such as mRNA and gene therapies into cells while protecting them. Worldwide, more than 2,000 LNP-related pipeline drugs are in the development stage. The demand for contract manufacturing for manufacturing drugs for clinical trials and commercial mass production is estimated to grow rapidly in the upcoming years. Citing the potential growth opportunities of LNPs, key market players are adopting aggressive growth strategies to enter into the lipid nanoparticles CDMO market.

  • In May 2023, Inventage Lab signed a co-development and manufacturing (CDMO) commercialization agreement with EuBiologics for LNP production.

Competitive Landscape Analysis: Lipid Nanoparticles CDMO Market

Some of the key and established players operating in the lipid nanoparticles CDMO market are Evonik Health Care, Merck, CordenPharma, Phosphorex, eTheRNA Manufacturing, Fujifilm Pharmaceuticals, Helix Biotech, BIOVECTRA, Vernal Biosciences.

Growth Strategies Adopted by the Market Players to Establish Their Dominance in the Lipid Nanoparticles CDMO Market

All leading and established players operating in the lipid nanoparticles CDMO market are adopting aggressive growth strategies such as expanding manufacturing capabilities, taking over other firms, and entering into partnerships with related firms to garner a higher market share. 

For instance, 
  • In March 2023, Evonik open new facilities in Lafayette, Indiana, in the United States and Hanau, Germany for pharmaceutical lipids.
  • In March 2022, CordenPharma increased its lipid manufacturing capacity to support mRNA vaccines.
The global lipid nanoparticles CDMO market is projected to experience a healthy growth in the coming years due to the growing application horizon of lipid nanoparticles across vaccines, cancer treatments, gene therapy products, and aggressive growth strategies adopted by the leading market players.

Get A FREE Sample Report on Lipid Nanoparticles CDMO Market @ https://meditechinsights.com/lipid-nanoparticles-cdmo-market/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Genomics Market Report Reveals Rapid Growth & Transformative Trends in the Genomic Industry by 2027

In the ever-evolving landscape of healthcare, genomics is making headlines for its groundbreaking contributions to personalized medicine, disease understanding, and advancements in pharmaceutical research. The Global Genomics Market Report for 2023 highlights the impressive growth and transformative trends within the genomics industry, shedding light on the exciting potential of genomics in shaping the future of healthcare. I. The Genomics Market Landscape The report's comprehensive analysis of the global genomics market reveals a dynamic and rapidly expanding landscape. With a CAGR of over [X]% during the forecast period, the industry is experiencing unprecedented growth. Key factors driving this growth include increased adoption of genomics in clinical diagnostics, expanding genomics research initiatives, and the development of advanced sequencing technologies. II. Personalized Medicine Revolution One of the most exciting trends highlighted in the report is the integration of ge
Read more

Global Ambulatory Surgical Center (ASC) Software Market is Poised to Grow at a CAGR of 10% by 2027

Ambulatory Surgical Care is a medical care offered in the outpatient setting and does not need any hospital admission. Ambulatory Surgical Center or ASCs—are health care facilities focused on offering same-day surgical care, including diagnostic and preventive procedures. ASCs have transformed the outpatient experience by offering a convenient alternative to hospital-based outpatient procedures. Common procedures performed in ASCs are cataract surgery, gallbladder removal, tonsillectomy, endoscopy, colonoscopy, arthroscopic or orthopedic procedures, and cardiac procedures. Owing to their various cost benefits and convenience, the volume of procedures performed at ASCs is rising and ASC software is likely to play a major role in these settings by easing the day to day operations by preparing staff and patients for pre-op and post-op tasks. Rising Investments in Ambulatory Surgical Center  from Healthcare Companies Shows a Huge Growth Potential for Ambulatory Surgical Center Software Ma
Read more